MELISSA MOORE: Open Payments
NPI 1336571298 · HINDMAN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 20 payments from 12 companies in 2025. Trend: 2023 $240 · 2024 $203 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| ABBVIE INC. | 2 | $80 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| PFIZER INC. | 2 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Agios Pharmaceuticals, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $18 |
Products named: LEQVIO, MAVYRET, JOURNAVX, TRELEGY ELLIPTA, Kerendia, ELIQUIS, AIRSUPRA, CAPLYTA.
Industry payments across KY — which companies pay providers there.
